Iovance Biotherapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Iovance Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iovance Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iovance Biotherapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.7M | 1.2M | 2.17 |
| 2025-03-31 | $4.3M | 1.3M | 3.33 |
| 2024-12-31 | $9.7M | 1.3M | 7.40 |
| 2024-09-30 | $18M | 1.9M | 9.39 |
| 2024-06-30 | $28M | 3.4M | 8.02 |
| 2024-03-31 | $65M | 4.4M | 14.82 |
| 2023-12-31 | $23M | 2.8M | 8.13 |
| 2023-09-30 | $13M | 2.7M | 4.55 |
| 2023-06-30 | $19M | 2.6M | 7.04 |
| 2023-03-31 | $11M | 1.9M | 5.71 |
| 2022-12-31 | $15M | 2.3M | 6.39 |
| 2022-06-30 | $23M | 2.0M | 11.18 |
| 2022-03-31 | $31M | 1.9M | 16.65 |
| 2021-12-31 | $38M | 2.0M | 18.82 |
| 2021-03-31 | $43M | 1.3M | 31.66 |
| 2020-12-31 | $44M | 943k | 46.40 |
| 2020-09-30 | $23M | 704k | 32.30 |
| 2020-06-30 | $17M | 626k | 27.45 |
| 2020-03-31 | $17M | 558k | 29.94 |
| 2019-12-31 | $15M | 536k | 27.68 |
| 2019-09-30 | $8.6M | 474k | 18.20 |
| 2019-06-30 | $11M | 464k | 22.61 |
| 2019-03-31 | $4.2M | 445k | 9.51 |
| 2018-12-31 | $4.0M | 449k | 8.84 |
| 2018-09-30 | $4.8M | 428k | 11.25 |
| 2018-06-30 | $5.6M | 436k | 12.80 |
| 2018-03-31 | $8.6M | 510k | 16.90 |
| 2017-12-31 | $10M | 1.3M | 7.98 |
| 2017-06-30 | $8.0M | 1.1M | 7.36 |